Abstract Hypertension, atherosclerosis, and resultant chronic heart failure (HF) reach epidemic proportions among older persons, and the clinical manifestations and the prognoses of these worsen with increasing age. Thus, age per se is the major risk factor for cardiovascular disease. Changes in cardiac cell phenotype that occur with normal aging, as well as in HF associated with aging, include deficits in ß-adrenergic receptor (ß-AR) signaling, increased generation of reactive oxygen species (ROS), and altered excitation-contraction (EC) coupling that involves prolongation of the action potential (AP), intracellular Ca 2? (Ca i 2? ) transient and contraction, and blunted forceand relaxation-frequency responses. Evidence suggests that altered sarcoplasmic reticulum (SR) Ca 2? uptake, storage, and release play central role in these changes, which also involve sarcolemmal L-type Ca 2? channel (LCC), Na ? -Ca 2? exchanger (NCX), and K ? channels. We review the age-associated changes in the expression and function of Ca 2? transporting proteins, and functional consequences of these changes at the cardiac myocyte and organ levels. We also review sexual dimorphism and self-renewal of the heart in the context of cardiac aging and HF.
Introduction
It is estimated that by 2035, nearly one in four individuals in the United States will be 65 years of age or older. Hypertension, atherosclerosis, and resultant chronic HF reach epidemic proportions among older persons, and the clinical manifestations and the prognoses of these worsen with increasing age. The reason is that, in older individuals, specific pathophysiological mechanisms that underlie these diseases become superimposed on heart and vascular substrates that are modified by the process of aging. In other words, cardiovascular aging is ''risky.'' An understanding of how age per se modifies cardiovascular structure and function is critical to the prevention or treatment of cardiovascular diseases in the older person.
Cardiac aging
Cellular and molecular mechanisms implicated in ageassociated changes in myocardial structure and function in humans have also been studied largely in rodents ( Table 1) . The altered cardiac structural phenotype that evolves with aging in rodents includes an increase in LV mass due to an enlargement of myocyte size [17] and focal proliferation of the matrix in which the myocytes reside, which may be linked to an altered cardiac fibroblast number or function. The number of cardiac myocytes becomes reduced because of necrosis and apoptosis, with the former predominating [2] . Putative stimuli for cardiac cell enlargement with aging in rodents include an age-associated increase in vascular load due to arterial stiffening and stretching of cells caused by drop out of neighboring myocytes [39] . Stretch of cardiac myocytes and fibroblasts initiates growth factor signaling (e.g. angiotensin II/TGF-ß) that, in addition to modulating cell growth and matrix production, leads to apoptosis [13] . The expression of atrial natriuretic [78] and opioid [11] peptides, molecules that are usually produced in response to chronic stress, is increased in the senescent rodent heart.
Reduced acute response to stress
Acute excess myocardial Ca 2? loading leads to dysregulation of Ca 2? homeostasis, impaired diastolic and systolic function, arrhythmias, and cell death [37] . The cell Ca 2? load is determined by membrane structure and permeability characteristics, the intensity of stimuli that modulate Ca 2? influx or efflux via their impact on regulatory function of proteins within membranes, and ROS, which affect both membrane structure and function. Excessive cytosolic Ca 2? loading occurs during physiological and pharmacological scenarios that increase Ca 2? influx (e.g. neurotransmitters, postischemic reperfusion, or oxidative stress) [23, 40] . In hearts or myocytes from the older heart, enhanced Ca 2? influx, impaired relaxation, and increased diastolic tone occur during pacing at an increased frequency [10, 45, 67, 79] . This is a ''downside'' of the aforementioned age-associated adaptation that occurs within the cells of senescent heart (and also of young animals chronically exposed to arterial pressure overload). Causes of reduced Ca 2? tolerance of the older heart include changes in the amounts of proteins that regulate Ca 2? handling, caused in part by altered gene expression (Tables 1 and 2) , and an age-associated alteration in the composition of membranes in which Ca 2? regulatory , calcium ions; Na/Ca exchanger, sarcolemmal sodium-calcium exchanger; MHC, myosin heavy chain; mRNA, messenger RNA; RXR, retinoid X-receptor; bAR, b-adrenergic receptor; bARK, b-adrenergic receptor kinase; G i , inhibitory G protein; TNI, troponin-I; 1 Ca , calcium influx via L-type Ca 2? channels; Ca i , intracellular calcium concentrations; HSF, heat shock factor; AT 1 R, angiotensin AR-1 receptor; RAS, renin-angiotensin system proteins reside, which includes an increase in membrane x 6 :x 3 polyunsaturated fatty acids (PUFAs) [55] . x 3 PUFAs are protective of cardiac Ca 2? regulation. An additional potential cause of the reduced threshold of senescent myocytes for Ca 2? overload is an enhanced likelihood for intracellular generation of ROS [40, 48] in cells from the senescent versus the younger adult heart during stress. In this regard, the older cardiac myocyte and endothelial cells [69] share common ''risks'' with aging.
Cellular ß-adrenergic signaling
Age-associated deficits in the myocardial ßAR signaling cascade also occur with aging (see [38] for review). A reduced myocardial contractile response to either ß 1 AR or ß 2 AR stimulation is observed with aging [57, 73, 74] . This is due to failure of ß-adrenergic stimulation to augment Ca i 2? to the same extent in cells of senescent hearts that it does in those from younger adult hearts [73] an effect attributable to a deficient increase of L-type sarcolemmal Ca 2? channel availability, which leads to a lesser increase in Ca 2? influx [73] . The richly documented age-associated reduction in the postsynaptic response of myocardial cells to ß-adrenergic stimulation seems to be due to multiple changes in the molecular and biochemical steps that couple the receptor to postreceptor effectors. However, the major limiting modification of this signaling pathway that occurs with advancing age in rodents seems to be the coupling of the ß-AR to adenylyl cyclase via the Gs protein and changes in adenylyl cyclase protein, which lead to a reduction in the ability to sufficiently augment cell cAMP and to activate protein kinase A (PKA) to drive the phosphorylation of key proteins that are required to augment cardiac contractility [31, 74] . In contrast, the apparent desensitization of ß-adrenergic signaling that occurs with aging does not seem to be mediated via increased ß-AR kinase or increased G i activity [74] . A blunted response to ß-adrenergic stimulation of the cells within older myocardium can, in one sense, be viewed as adaptive with respect to its effect to limit the risk of Ca 2? overload and cell death in these cells.
Reduced chronic adaptive capacity of the older heart
Many of the multiple changes in cardiac structure, excitation, myofilament activation, contraction mechanisms, Ca 2? dysregulation, deficient ß-AR signaling, and altered gene expression of proteins involved in EC coupling that occur with aging (Tables 1 and 2 ) also occur in the hypertrophied myocardium of younger animals with experimentally induced chronic hypertension [38, 77] and in failing animal or human hearts, in which they have been construed as an adaptive response to a chronic increase in LV loading. When chronic mechanical stresses that evoke substantial myocardial hypertrophy (e.g. pressure or volume overload) are imposed on the older heart, the response in many instances is reduced. There is evidence that transcriptional events associated with hypertrophic stressors become altered with advancing age, e.g. the nuclear binding activity of the transcription factor nuclear factor-jB is increased and that of another transcription factor, Sp1, is diminished [24] . Because these transcription factors each influence expression of a number of genes, they may contribute to the pattern of gene expression observed in the hearts of senescent rodents and may also dictate the limits of adaptive responses to the imposition of additional chronic stress. The acute induction of both immediate early genes and later responding genes that are expressed during the hypertrophic response is blunted in hearts of aged rats after aortic constriction [60, 66] . Similarly, the acute induction of heat shock 70 protein genes in response to either ischemia or heat shock is reduced in hearts of senescent rats [9, 52] . A similar loss of adaptive capacity is observed in younger rats that have used a part of their reserve capacity before a growth factor challenge [61] . Table 2 , the majority of studies in aging vs. younger rats have shown a significant reduction in protein levels of SERCA2 [5, 58, 65, 80] . On the other hand, most studies in aging mice have shown unchanged levels of SERCA2 [27, 46, 63] . Apart from the phosphorylation status of SERCA2-PLB complex, discussed later, SR Ca 2? uptake is dependent on the relative levels of both proteins, i.e. reduced at lower SERCA2/PLB ratio [50] . The majority of studies reporting expression levels of both SERCA2 and PLB showed reduced SERCA2/PLB ratios in aging rodent hearts ( Table 2) . Increasing SERCA/PLB ratio through in vivo gene transfer of SERCA2a markedly improved rate-dependent contractility and diastolic function in 26-months-old rat hearts [58] . Functional improvement consequent to increasing SERCA/PLB ratio by PLB suppression was also reported in human failing myocytes [14] . On the other hand, PLB ablation in transgenic mouse models of HF was beneficial only in some models (reviewed in [4] and [50] ).
Age-associated decline in the Ca 2? -sequestering activity of SERCA2 in rodent myocardium has been well documented both by biochemical studies in isolated SR vesicles and by biophysical studies in cardiac preparations [18, 35, 58, 65, 76] . Apart from reduced content of SERCA2 or SERCA2/PLB ratio, discussed earlier, lower pumping activity of SERCA2 in aging myocardium may result from reduced phosphorylation of the SERCA2-PLB complex. Specifically, in its unphosphorylated state, PLB interacts with SERCA2 exerting an inhibitory effect manifested largely through a decrease in the enzyme's affinity for Ca 2? . Phosphorylation of PLB by PKA and/or Ca 2? /calmodulindependent protein kinase (CaMK) is thought to disrupt this interaction resulting in enhanced affinity of the ATPase for Ca 2? and stimulation of Ca 2? pump activity [50] . Besides PLB, CaMK has been suggested to modulate the SR Ca 2? uptake and release through direct phosphorylation of SERCA2 [75] . The well established deficits in ß-AR signaling that occur in aging humans and animals [38] include significantly lower PKA-dependent phosphorylation of PLB in aged vs. adult rat ventricular myocardium [31] . Recent studies have also shown that significant age-associated decrements occur in (1) the amount of CaMK (d-isoform) in the rat heart, (2) the endogenous CaMK-mediated phosphorylation of SERCA and PLB, and (3) the phosphorylation-dependent stimulation of SR Ca 2? sequestration [76] . Increased activity of the SR-associated phosphatase PP1, which dephosphorylates PLB, had already been reported, and overexpression of PP1 in transgenic mice resulted in HF. PP1 activity was further shown to be regulated by the inhibitor I-1, and I-1 was found to be reduced in human HF (reviewed in [62] ). However, potential agerelated changes in the activity of cardiac phosphatases have yet to be examined. influx through LCC, as well as during cardiac relaxation and diastole. Accordingly, alterations in the expression or function of RYR have been implicated in both systolic and diastolic dysfunction of the aging heart. Reduced protein expression of cardiac RYR has been reported in aging Wistar rats [5] , but not Fisher 344 rats [58, 76, 80] ( Table 2 ). The RYR is phosphorylated by PKA and CaMK, and a significant reduction in the CaMK-mediated phosphorylation of the RYR has been shown to occur in the aged compared with adult Fisher 344 rats [76] . Single channel properties of RYR and unitary SR Ca 2? release events (Ca 2? sparks) in ventricular cardiomyocytes were recently examined in hearts from 6-to 24-month-old Fisher 344 rat [80] . [26, 80] might be partly related to differences in species and experimental conditions (e.g. temperature) employed. However, consistent with previous findings [23] , both these studies [26, 80] [23, 37] . The PKA-mediated hyperphosphorylation of RYR, resulting in abnormal SR Ca 2? leak through the RYR, has been implicated in both diastolic and systolic dysfunction of the failing heart [51] . However, more recent evidence points to CaMKII site phosphorylation of RYR in normal cardiac tissue [22, 43] , and a potential role and mechanism for PKA modulation of this process in the pathophysiology of HF associated with aging remains lacking.
SR

Calsequestrin
Reports have consistently shown that aging does not alter CSQ expression at either the transcriptional ( [32] . The age-associated changes in I CaL are summarized in Table 3 .
Maintained peak density of I CaL has been shown in ventricular myocytes from senescent (21-25 months) vs. young (2-3 months) male Wistar rats [71, 73] , and in 20-22 vs. 10-to 12-mo-old male FVB mice [68] . I CaL inactivates more slowly in myocytes from older vs. younger Wistar rats [32, 71] , and this, as well as reductions in peak transient outward K
? current (I TO ) [71] , might partially account for prolongation of the AP reported in senescent Wistar and Fisher 344 rat hearts [71, 72] . Experiments in ventricular myocytes isolated from young adult (6 mo) and aged ([27 mo) Fischer 344 and Long-Evans rats showed an ageassociated decrease in peak density of I CaL accompanied by a slower inactivation, and a greater amplitude of I TO [47] . Compared to young myocytes, AP duration in aged myocytes was longer at 90% of repolarization but shorter 20 and 75% of repolarization [47] . In ventricular myocytes isolated from young (2 mo) and senescent (20-27 months) C57/BL6 mice (sex unspecified), peak I CaL density was similar at stimulation rates of 2-8 Hz, but higher in aged group at 0.4 and 1 Hz [27] . These experiments also showed that the I CaL time integral (a function of peak amplitude and inactivation rate) normalized to cell capacitance was similar in both age groups under 2-6 Hz stimulation. Compared to young cells, I CaL time integral in aged myocytes was significantly smaller at 8 Hz and larger at 0.4 Hz [27] . Experiments in ventricular myocytes isolated from young adult (*7 mo) and aged (*24 mo) male and female B6SJLF1/J mice [21] stimulated at 2 Hz, showed a significant reduction in peak I CaL density, accompanied by a significantly slower inactivation, in aged vs. young adult myocytes from males. No age-related changes in I CaL characteristics were found in the female group. In myocytes isolated from the hearts of young (18 months) and aged ([8 years) female sheep, the AP duration and both the peak I CaL and integrated Ca 2? entry were significantly greater in aged cells [15] . Ca 2? influx via LCC is a complex function of several interdependent mechanisms, including (1) voltage-dependent modulation, (2) Ca 2? -dependent modulation via direct binding to LCC of Ca 2? -calmodulin and via CaMKII, and (3) b-adrenergic modulation via PKA. In aging myocardium, voltage-dependent changes may be consequent to prolongation of the AP duration and manifested by reduced peak amplitude accompanied by slower inactivation/larger time integral of I CaL (e.g. [29] ). Ca 2? -mediated effects may contribute to frequency-dependent reduction in the amplitude and time integral of I CaL (e.g. [27] ) due to rate-dependent diastolic Ca 2? accumulation, which has been shown to slow the rate of LCC recovery from inactivation in both normal and failing cardiac myocytes (reviewed in [7] ). In addition, Ca 2? -mediated crosstalk between LCC and RYR, well established in normal myocardium [7] , may facilitate Ca 2? influx via LCC in the presence of slower and/or smaller SR Ca 2? release in aging myocardium. For instance, buffering of Ca i 2? with EGTA eliminated age-related differences in the AP configuration and the time course of I CaL inactivation in myocytes from senescent and young rats [71] . As discussed earlier, aging is associated with deficits in the myocardial ß-AR signaling cascade [38] that includes reduced stimulation of the I CaL [73] through PKA-mediated changes in the availability and gating properties of LCC.
Na
? -Ca 2? exchanger
The NCX serves as the main transsarcolemmal Ca 2? extrusion mechanism and is centrally involved in the beat-to-beat regulation of cellular Ca 2? content and cardiac contractile force, including regulation of the AP configuration in the late repolarization phase and the later Ca 2? clearance phase of the Ca i 2? transient. Thus, alterations in NCX activity may contribute to the prolongation of both the AP duration and relaxation in aging myocardium (Lakatta, 1993) . Age-related increase in the NCX expression has been demonstrated at the transcriptional level (Table 1) . However, protein levels of NCX reported in aging rodent hearts were unchanged [44, 49, 58] or reduced [5, 28, 46] (Table 2) .
The results of experiments using enriched sarcolemmal vesicles or muscle strips isolated from rats were also inconsistent, i.e. the NCX activity in aged myocardium was decreased [25, 28] , increased [19] , or unchanged [1] . More recent functional assessments of NCX activity in cardiac myocytes isolated from young (14-15 mo) and aged (27-31 mo) male Fischer Brown Norway rats [49] showed that under conditions where membrane potential and intracellular [Na ? ] and [Ca 2? ] could be controlled, ''forward'' NCX activity was increased in aged vs. young cells. The increased ''forward'' NCX activity was interpreted as a factor contributing to the late AP prolongation in aging myocardium [49] . Such increased Ca 2? efflux via NCX would compensate for increased Ca 2? influx via LCC [15, 32, 71] . Prolongation of the AP consequent to reduced I TO [71] may temporarily limit ''forward'' NCX during relaxation, allowing better SR Ca 2? reuptake by SERCA2 [29] and Fig. 2 .
Excitation-contraction coupling in the aging heart
Coordinated changes in the expression and function of proteins that regulate several key steps of the cardiac EC coupling process occur in the rodent heart with aging and typically result in a prolonged AP, a prolonged Ca i 2?
transient, a prolonged contraction, and blunted inotropic and lusitropic responses to increased pacing rate (Figs. 1, 3  and 4) .
Age-related prolongation of the AP [15, 49, 71, 72 ] is thought to stem, in part at least, from increased number and the activity of individual cardiac L-type Ca 2? channels [32] , slower inactivation of I CaL [15, 32, 71] , and reductions in outward K ? currents [71] . Additionally, the late repolarization phase of the AP may be prolonged by increased Ca 2? efflux via NCX [49] . Of particular interest is the role of I TO as an indirect modulator of EC coupling in cardiac cells (reviewed by Bassani [6] ). Specifically, recent studies have provided evidence that the early repolarization phase may considerably influence the entire AP waveform and that I TO is the main current responsible for this phase. Decreased I TO density is observed in immature and aging myocardium, as well as during several types of Fig. 1 Differences in various aspects of excitationcontraction coupling mechanisms measured between adult (6-9 months) and senescent (24-26 months) rat hearts. a Transmembrane action potential and b isometric contraction (from [72] release and greater propensity to triggered arrhythmias [6] . The imposition of a shorter AP to myocytes from the old rat heart reduces the amplitude and the rate of decline of the Ca i 2? transient [29] . This is attributable to a reduction in the SR Ca 2? uptake and loading which, in the presence of a reduced rate of Ca 2? sequestration by SERCA2, is presumably due to a reduced I CaL time integral and likely also to an increased net Ca 2? extrusion via NCX (Fig. 2) [29] . A slower decay of the Ca i 2? transient is a hallmark of aged cardiac myocyte (Figs. 1, 2, 3, 4 , and Table 1 ). Reduction in the amplitude of the Ca i 2? transient in myocytes from aged hearts, compared to younger counterparts, has been reported in some studies already at low (B2 Hz) stimulation rates [21, 80] . Examinations using a range of stimulation rates [27, 45] typically showed blunted forceand relaxation-frequency responses in myocytes from old vs. young hearts. Thus, while the age-related differences in the amplitude and the rate of decay of the Ca i 2? transients (and diastolic Ca i 2? levels) were small or absent at low stimulation rates, they became apparent and progressively larger at pacing rates approximating those in vivo (Fig. 3 ) [27, 45] . Likewise, abrupt changes in the stimulation rate reveal an impaired SR Ca 2? release in ventricular myocytes isolated from senescent vs. young rats (Fig. 4) . Specifically, in the presence of similar kinetics of I CaL recovery, reduction in the amplitude of the Ca i 2? transients and the gain of I CaL -dependent Ca 2? release during premature depolarizations are attributable to a slower rate of SR Ca 2? reuptake in older myocytes (Fig. 4) . Taken together, these results are consistent with a reduced adaptive capacity of the older heart to physiological stress, i.e. pacing rate and b-adrenergic stimulation (see [38] for review), and underscore the value of appropriate experimental design in examining potential age-related differences in cardiac phenotype. Another characteristic of agerelated changes in the configuration of the Ca i 2? transient, reported in several (Fig. 1) and [27] but not all [21, 45] studies, is a prolonged time to peak Ca i 2? . In cardiac myocytes, the development of the Ca i 2? transient is dependent primarily on the amount and the rate of Ca 2? release from the SR, and the decline of the Ca i 2?
transient and the amount of Ca 2? available for subsequent release are dependent primarily on Ca 2? sequestration by the SR. Age-related reduction in the rate of rise and the amplitude of the Ca i 2? transient (systolic dysfunction), as well as the rate of decline of the Ca i 2? transient (diastolic dysfunction), appear to result, in large part, from impaired Ca 2? pumping by SERCA2. These changes have been extensively documented in biochemical and functional studies [18, 35, 58, 65, 76] . At the molecular level, they are attributable to a reduced protein expression of SERCA2 or its ratio to PLB (Table 2 ) and/or reduced phosphorylation of the SERCA2-PLB complex by PKA and CaMK [31, 75, 76] . A shift of SERCA2b distribution to the subsarcolemmal space has also been suggested [27] . Age-related alterations in the gating properties of RYR [26, 80] , resulting in an increased SR Ca 2? leak, may also contribute to both diastolic and systolic dysfunction of the aging myocardium by limiting the net rate of SR Ca 2? sequestration and SR Ca 2? loading, respectively. Finally, a slower rate of development/ longer time to peak of the Ca i 2? transient in aging myocytes is likely to result from reduced SR Ca 2? loading but may be also consequent to a longer time to peak I CaL [71] , which synchronizes SR Ca 2? release. Prolonged time to peak and slower relaxation of contraction, typical for aged myocardium (Figs. 1 and 3) [21, 45, 46, 64, 67, 80] are attributable to both changes in the aMHC and bMHC protein ratio (Table 1 ) [38] and in the configuration of the Ca 2? transient. Clearly, the latter underlies impaired frequency-dependent inotropic and lusitropic responses [21, 45, 46, 58, 59 ] that largely contribute to the systolic and diastolic dysfunction of the aging heart. Consistent with the major role of SERCA2 in these effects, studies in rat isolated cardiac muscle preparations have shown that exercise training reverses age-associated slowing of contraction and relaxation [64, 67] . This was associated with increased Ca 2? transport by SERCA2 but not myosin ATPase activity in cardiac homogenates [67] . Likewise, overexpression of SERCA2 markedly improved rate-dependent contractility and contractile function in senescent rat hearts [58] .
Sex-related differences
Biological sex is a well-recognized factor in the physiology and pathophysiology of the cardiovascular system, including the aging heart (reviewed in [41] and [36] ). However, despite the growing number of reports in the literature identifying sex-related differences in cardiac function in both humans and rodents, the underlying mechanisms remain incompletely understood.
New insights into the molecular bases of sexual dimorphism in the context of aging and cardiovascular disease have been recently afforded by large-scale analyses of gene expression at the transcriptional level using microarrays. Specifically, Boheler and colleagues [8] have identified several HF-dependent gene products that may act as potential regulators for transducing mechanical, stress and neurohormonal stimuli into changes in gene expression. Most HF-candidate genes demonstrated significant changes in gene expression; however, the majority of differences among samples depended on variables such as sex and age, and not on HF alone. Some HF-responsive gene products also demonstrated highly significant changes in expression as a function of age and/or sex, but independent of HF. These results emphasize the need to account for biological variables (HF, sex, and age interactions) to elucidate genomic correlates that trigger molecular pathways responsible for the progression of HF syndromes. Subsequent analysis of gene expression differences by sex and age in left ventricular samples from patients with dilated cardiomyopathy has identified more than 1,800 genes displaying sexual dimorphism in the heart. A significant number of these genes were highly represented in gene ontology pathways involved in ion transport and G protein-coupled receptor signaling [16] .
Postmortem morphometric assessments in non-failing human hearts have shown extensive age-related myocyte loss and hypertrophy of the surviving myocytes in males, but preserved ventricular myocardial mass, average cell diameter, and volume in aging female hearts [53] . These sex differences may stem, in part, from differences in the replicative potential of cardiac myocytes. For instance, the activity of telomerase, an enzyme present only during cell replication, was decreased 31% in aging male rat myocytes, but increased 72% in female counterparts [42] . Premature development of HF or death in males compared to matching females has been documented in rat models of pressure overload and/or myocardial infarction (reviewed in [36] ). Sexually dimorphic cardiac phenotypes have been also discovered in some studies in genetically engineered mice (Table 4) [36, 41] . In general, transgenic models of HF present a more rapid onset and/or a greater severity of cardiac dysfunction in male vs. female hearts. For instance, mice with cardiac-specific overexpression of tumor necrosis factor-a (TNF-a) exhibit HF and increased mortality that is markedly higher in young males than females (*50% and 4%, respectively, by 20 weeks of age) [33] . At 12 weeks of age, female mice displayed LV hypertrophy without dilatation and only a small reduction of basal LV fractional shortening and response to isoproterenol (Iso), while male mice showed a large LV dilatation, reduced fractional shortening relative to both wild-type littermates and transgenic females, and minimal response to Iso [30] . Cardiac myocyte hypertrophy was similar in male and female transgenic mice. Compared to wild-type mice, myocytes from female TNF-a transgenic mice displayed a slower decline of the Ca i 2? transient, but similar amplitudes of Ca i 2? transients and contractions and the inotropic response to Iso. In contrast, the amplitude and the rate of decline of Ca i 2? transients and contractions, and the response to Iso were significantly reduced in myocytes from male transgenic TNF-a mice [30] .
These studies underscore the value of considering biological sex and age in the assessment of cardiac phenotypes. However, inspection of the literature shows that the majority of studies in animal models of human cardiac disease has been carried out only in males or do not indicate which sex was studied. The same applies to studies of myocardial changes with adult aging, including molecular changes (Table 2) . Remarkably, the available examinations of cardiac EC coupling in rodents of both sexes [21] or females only [70] show a lack of age-related changes in the configuration of the Ca i 2? transient in myocytes from female hearts. Specifically, Grandy and Howlett [21] have reported a significant reduction in the I CaL density, amplitudes of the Ca i 2? transients, fractional cell shortening, and the SR Ca 2? content in ventricular myocytes isolated from the hearts of aged (*24 mo) vs. young adult (*7 mo) male mice. In contrast, I CaL density, the amplitude of Ca i 2? transients and fractional cell shortening were similar in young adult and aged myocytes from female hearts, while the SR Ca 2? content was increased in the aged female group. Accordingly, fractional SR Ca 2? release was similar in both age groups of male myocytes but reduced in aged vs. young adult female myocytes. The gain of EC coupling was similar in young adult and aged myocytes, regardless of the sex of the animal. The somewhat unexpected findings of this study in aged female myocytes include (a) an apparent increase in the SR Ca 2? content, (b) the lack of the effect of the latter on the configuration of the Ca i 2? transients and contraction, and (c) a reduction of fractional SR Ca 2? release, in the presence of unchanged I CaL. Nevertheless, these results provide an initial direct demonstration of sexually dimorphic changes in cardiac EC coupling associated with normal adult aging. Small heart: ; exercise performance ; Aortic restriction response; heart normal following ovariectomy [3] Constitutively active Akt Heart size : compared to wild type Heart size : compared to wild type; heart size : compared to transgenic males [44] Mutant a-MyHC Cardiac chamber dilatation; heart failure Hypertrophy; preserved function [58] Mutant cardiac troponin T (R92Q) [15] . However, a potential sex aspect of this finding has not been explored.
Myocyte progenitors in the aging heart
Studies by Anversa and colleagues (reviewed in [3, 34] ) have demonstrated that the heart is a self-renewing organ containing a pool of progenitor cells (PCs) that dictate cell turnover, organ homeostasis and myocardial aging.
Observations in humans and animals suggest that myocyte maturation and aging are characterized by loss of replicative potential, telomeric shortening and the expression of the senescence-associated protein/cell cycle inhibitor p16
INK4a [12, 20, 56] . Telomeric shortening in PCs leads to generation of progeny that rapidly acquires the senescent phenotype. As discussed earlier, the latter involves progressive increase in the size of the cell (up to a critical volume beyond which myocyte hypertrophy is no longer possible), deficits in the electrical, Ca 2? cycling and mechanical properties, and cell death. Cardiac myocytes with senescent and non-senescent phenotypes already coexist at young age [56] . However, aging limits the growth and differentiation potential of PCs, thus interfering not only with their ability to sustain physiological cell turnover but also with their capacity to adapt to increases in pressure and volume loads [3, 34] .
The loss of PC function with aging is mediated partly by an imbalance between factors enhancing oxidative stress, telomere attrition and death, and factors promoting growth, migration, and survival. Recent findings suggest a preeminent position of insulin-like growth factor-1 (IGF-1) among factors that interfere with cardiac cellular senescence. Specifically, cardiac-restricted overexpression of IGF-1 in transgenic mice has been shown to delay the aging myopathy and the manifestations of HF [68] and to restore SERCA2a expression and rescue age-associated impairment of cardiac myocyte contractile function [44] . The latter effect was also partly mimicked by short-term in vitro treatment with recombinant IGF-1 [44] . Furthermore, intramyocardial delivery of IGF-1 improved senescent heart phenotype in male Fisher 344 rats [20] , including increased proliferation of functionally competent PCs and diminished angiotensin II-induced apoptosis. Myocardial regeneration mediated by PC activation attenuated ventricular dilation and the decrease in ventricular mass-to-chamber volume ratio, resulting in improvement of in vivo cardiac function in animals at 28 to 29 months of age [20] .
Thus, understanding the biology of cardiac PCs, including factors enhancing the activation of the PC pool, their mobilization, and translocation may facilitate the development of novel strategies to prevent or reverse the diminished adaptive capacity to increases in pressure and volume loads (and perhaps HF) in the old population.
Summary
The occurrence, clinical manifestations and prognoses of HF worsen with increasing age because the underlying pathophysiological mechanisms become superimposed on heart and vascular substrates that are modified by the process of aging. Changes in the cardiac cell phenotype associated with aging include (1) enlargement of the myocyte size, consequent to increase in vascular load and loss of neighboring myocytes, (2) reduced acute response to stress, consequent to deficits in ß-AR signaling, changes in the composition of the cell membranes and enhanced intracellular generation of ROS, and (3) currents. Studies of sexual dimorphism in the context of cardiac aging and HF and the expansion of the concept of the heart as a continuously self-renewing organ may assist in our understanding the pathophysiology of cardiovascular aging and in the development of effective therapeutic strategies.
